Gabaeron, Inc is a San Francisco-based biotechnology company that specializes in the development of precision medicine and regenerative medicine solutions for neurological disorders. Their innovative approach combines the use of genetically defined apoE genotype-associated neuropathology, regenerative medicine techniques, and pharmaceutical intervention to restore lost neurons and protect against neurodevelopmental disorders.
With a focus on Alzheimer's disease and other neurodegenerative diseases, as well as the neurodevelopmental disorder Smith-Lemli-Opitz syndrome, Gabaeron aims to develop first-in-class treatments using human iPSC-derived GABAergic inhibitory interneurons and small molecule drugs. Their groundbreaking research and pipeline projects offer hope for patients by addressing the underlying causes of these disorders and providing potential solutions for neuron replacement and protection.
Generated from the website